Correlation Between MaxCyte and Inari Medical
Can any of the company-specific risk be diversified away by investing in both MaxCyte and Inari Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and Inari Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and Inari Medical, you can compare the effects of market volatilities on MaxCyte and Inari Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of Inari Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and Inari Medical.
Diversification Opportunities for MaxCyte and Inari Medical
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between MaxCyte and Inari is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and Inari Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inari Medical and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with Inari Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inari Medical has no effect on the direction of MaxCyte i.e., MaxCyte and Inari Medical go up and down completely randomly.
Pair Corralation between MaxCyte and Inari Medical
Given the investment horizon of 90 days MaxCyte is expected to under-perform the Inari Medical. In addition to that, MaxCyte is 1.08 times more volatile than Inari Medical. It trades about -0.01 of its total potential returns per unit of risk. Inari Medical is currently generating about 0.01 per unit of volatility. If you would invest 5,916 in Inari Medical on September 2, 2024 and sell it today you would lose (724.00) from holding Inari Medical or give up 12.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MaxCyte vs. Inari Medical
Performance |
| Timeline |
| MaxCyte |
| Inari Medical |
MaxCyte and Inari Medical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MaxCyte and Inari Medical
The main advantage of trading using opposite MaxCyte and Inari Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, Inari Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inari Medical will offset losses from the drop in Inari Medical's long position.| MaxCyte vs. Sight Sciences | MaxCyte vs. CVRx Inc | MaxCyte vs. Neuropace | MaxCyte vs. Rapid Micro Biosystems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |